Kåre Schultz
2020
In 2020, Kåre Schultz earned a total compensation of $15.7M as President and Chief Executive Officer at Teva Pharmaceutical Industries, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,055,920 |
|---|---|
| Salary | $2,000,000 |
| Stock Awards | $9,999,970 |
| Other | $668,628 |
| Total | $15,724,518 |
Schultz received $10M in stock awards, accounting for 64% of the total pay in 2020.
Schultz also received $3.1M in non-equity incentive plan, $2M in salary and $668.6K in other compensation.
Rankings
In 2020, Kåre Schultz's compensation ranked 368th out of 13,090 executives tracked by ExecPay. In other words, Schultz earned more than 97.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 368 out of 13,090 | 97th |
Division Manufacturing | 125 out of 5,621 | 98th |
Major group Chemicals And Allied Products | 43 out of 2,254 | 98th |
Industry group Drugs | 38 out of 1,954 | 98th |
Industry Pharmaceutical Preparations | 26 out of 1,459 | 98th |
Source: SEC filing on April 21, 2021.
Schultz's colleagues
We found four more compensation records of executives who worked with Kåre Schultz at Teva Pharmaceutical Industries in 2020.
2020
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2020
Brendan O'Grady
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
2020
Eric Drap
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2020
Eli Kalif
Teva Pharmaceutical Industries
Chief Financial Officer
News
Teva Pharmaceutical Industries CEO Kåre Schultz's 2021 pay slips 7% to $15M
April 13, 2022
Teva Pharmaceutical Industries CEO Kåre Schultz's 2020 pay jumps 36% to $16M
April 21, 2021
Teva Pharmaceutical Industries CEO Kåre Schultz's 2019 pay falls 64% to $12M
April 22, 2020
Teva Pharmaceutical Industries CEO Kåre Schultz's 2018 pay jumps 91% to $32M
April 16, 2019